Ogan Abaan, Ph.D.

Ogan is a strategic precision medicine leader and translational scientist with over 18 years of experience driving the global adoption of genomics and next-generation sequencing (NGS) applications. A cancer research scientist by training, Ogan has a proven track record of leading complex, cross-functional teams to execute enterprise-level diagnostic strategies. With a career spanning roles at industry leaders such as Illumina, Seven Bridges Genomics, and Lockheed Martin, he specializes in translating intricate technical concepts into impactful business strategies and strategic partnerships. At Kailos Genetics, Ogan leverages this expertise to foster laboratory excellence and innovation, accelerating the delivery of clinically meaningful genomic testing to ensure equitable healthcare outcomes and broadened access to precision medicine for all.